Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Stocchi

Showing results (161-170 of 254) with videos related to

Pageof 26
Sort By:
Journal of Neurology|August 20, 2024
Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studiesJoaquim J Ferreira, Jee-Young Lee, Hyeo-Il Ma, et al.
Expert Opinion on Pharmacotherapy|October 17, 2012
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's diseaseUbaldo Bonuccelli, Giuseppe Meco, Giovanni Fabbrini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2011
Wearing-off scales in Parkinson's disease: critique and recommendationsAngelo Antonini, Pablo Martinez-Martin, Ray K Chaudhuri, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 16, 2024
Resting-state EEG rhythms are abnormal in post COVID-19 patients with brain fog without cognitive and affective disordersClaudio Babiloni, Elio Gentilini Cacciola, Federico Tucci, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 19, 2014
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in ItalyDomenico Italiano, Elisa Bianchini, Maura Ilardi, et al.
Frontiers in Neurology|November 16, 2020
Abnormalities of Cortical Sources of Resting State Delta Electroencephalographic Rhythms Are Related to Epileptiform Activity in Patients With Amnesic Mild Cognitive Impairment Not Due to Alzheimer's DiseaseClaudio Babiloni, Giuseppe Noce, Carlo Di Bonaventura, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled studyKarla Eggert, David Squillacote, Paolo Barone, et al.
JAMA Neurology|August 14, 2023
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical TrialRobert A Hauser, Alberto J Espay, Aaron L Ellenbogen, et al.
Frontiers in Aging Neuroscience|April 10, 2026
Effects of combined Mediterranean diet and physical activity intervention on the gut microbiome and disease progression in individuals with Parkinson's disease: study protocol for a multicenter, randomized controlled pilot study (PRIME study)Alice Fognani, Rossella Rotondo, Maria Luisa Savo Sardaro, et al.
Lancet (London, England)|February 1, 2005
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's diseaseAlessio Di Fonzo, Christan F Rohé, Joaquim Ferreira, et al.
Pageof 26

Showing results (161-170 of 254) with videos related to

Sort By:
Pageof 26
Journal of Neurology|August 20, 2024
Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studiesJoaquim J Ferreira, Jee-Young Lee, Hyeo-Il Ma, et al.
Expert Opinion on Pharmacotherapy|October 17, 2012
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's diseaseUbaldo Bonuccelli, Giuseppe Meco, Giovanni Fabbrini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2011
Wearing-off scales in Parkinson's disease: critique and recommendationsAngelo Antonini, Pablo Martinez-Martin, Ray K Chaudhuri, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 16, 2024
Resting-state EEG rhythms are abnormal in post COVID-19 patients with brain fog without cognitive and affective disordersClaudio Babiloni, Elio Gentilini Cacciola, Federico Tucci, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 19, 2014
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in ItalyDomenico Italiano, Elisa Bianchini, Maura Ilardi, et al.
Frontiers in Neurology|November 16, 2020
Abnormalities of Cortical Sources of Resting State Delta Electroencephalographic Rhythms Are Related to Epileptiform Activity in Patients With Amnesic Mild Cognitive Impairment Not Due to Alzheimer's DiseaseClaudio Babiloni, Giuseppe Noce, Carlo Di Bonaventura, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled studyKarla Eggert, David Squillacote, Paolo Barone, et al.
JAMA Neurology|August 14, 2023
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical TrialRobert A Hauser, Alberto J Espay, Aaron L Ellenbogen, et al.
Frontiers in Aging Neuroscience|April 10, 2026
Effects of combined Mediterranean diet and physical activity intervention on the gut microbiome and disease progression in individuals with Parkinson's disease: study protocol for a multicenter, randomized controlled pilot study (PRIME study)Alice Fognani, Rossella Rotondo, Maria Luisa Savo Sardaro, et al.
Lancet (London, England)|February 1, 2005
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's diseaseAlessio Di Fonzo, Christan F Rohé, Joaquim Ferreira, et al.
Pageof 26